On May 12, Organigram Global Inc (NASDAQ:OGI) reported its March quarter results and issued guidance for 2026 revenue. The March quarter report showed net revenue declined 9% YoY to $59.8 million.
The CBD sector is showing signs of entering a more mature and sustainable growth phase. This shift is drawing renewed investor attention to CBD stocks.